Biosimilar
Hormones
Global Market
Report 2022
Market Size, Trends and
Global Forecast 2022-2026
@The Business Research Company. All rights reserved.
Biosimilar Hormones Market Characteristics:
The global biosimilar hormones market size is expected to grow from $1.74 billion in 2021 to $2.31
billion in 2022 at a compound annual growth rate (CAGR) of 32.5%. The biosimilar hormones
market is expected to reach $6.22 billion in 2026 at a CAGR of 28.1%.
The report covers the biosimilar hormones market’s segments-
By Type
Teriparatide
Biosimilars, Follitropin
Alfa Biosimilars,
Insulin Biosimilars,
Somatropin
Biosimilars, Others
By Application
By Distribution Channel
Research and
Biotechnology,
Diagnostics,
Biocatalysts,
Therapeutics, Others
Hospital and Retail
Pharmacy, Online
Pharmacy/ePharmacy,
Speciality Clinics
@The Business Research Company. All rights reserved.
Biosimilar Hormones Global Market Report 2022 is the most
comprehensive report available on this market, and helps
gain a truly global perspective as it covers 60 geographies
worldwide.
It identifies top countries and segments for opportunities and
strategies based on market trends and leading competitors’
approaches. The report provides market size and growth
forecasts for the global template market, global market
share, market segments, and so much more.
Click Here To View Complete Report
@The Business Research Company. All rights reserved.
Key Market Players
Major companies in the market include
Click Here To Get
A Sample Report
Teva Pharmaceutical
Gedeon Richter
Intas Pharmaceuticals
Biocon
Mylan
@The Business Research Company. All rights reserved.
How Can The Report Help You?
Gain a truly global perspective with the most
comprehensive market research report available on this
market covering 60+ geographies
Create regional and country strategies on the basis of local
data and analysis
Understand how the market is being affected by COVID-19
and how it is likely to emerge and grow as the impact of the
coronavirus abates